Übersichtsarbeit
TNFα as Therapeutic Target: New Drugs, More Applications
Current Drug Target -Inflammation & Allergy · 2002
DOI: 10.2174/1568010023344535 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Drug Target -Inflammation & Allergy, 2002. Verfasst von A M Reimold. Beteiligte Einrichtung: Rheumatic Diseases Division, Dept. of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75390-8884, USA. Andreas.Reim…. Die Arbeit wurde bisher 69-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Anti-Inflammatory Agents, Non-SteroidalAntibodies, MonoclonalAntirheumatic AgentsArthritis, RheumatoidAutoimmune DiseasesCrohn DiseaseEtanerceptHumansImmunoglobulin GInfectionsInflammationInfliximabRandomized Controlled Trials as TopicReceptors, Tumor Necrosis FactorSpondylarthritisTumor Necrosis Factor-alpha
Substanzen
Anti-Inflammatory Agents, Non-SteroidalAntibodies, MonoclonalAntirheumatic AgentsImmunoglobulin GReceptors, Tumor Necrosis FactorTumor Necrosis Factor-alphaInfliximabEtanercept
Autor:innen und Institutionen
- Rheumatic Diseases Division, Dept. of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75390-8884, USA. Andreas.Reimold@UTSouthwestern.edu
Zitieren
APA
Reimold, A. M. (2002). TNFα as Therapeutic Target: New Drugs, More Applications. Current Drug Target -Inflammation & Allergy. https://doi.org/10.2174/1568010023344535
Vancouver
Reimold AM. TNFα as Therapeutic Target: New Drugs, More Applications. Current Drug Target -Inflammation & Allergy. 2002. doi:10.2174/1568010023344535
BibTeX
@article{Reimold2002,
author = {Reimold, A M},
title = {TNFα as Therapeutic Target: New Drugs, More Applications},
journal = {Current Drug Target -Inflammation & Allergy},
year = {2002},
doi = {10.2174/1568010023344535}
}
EUVIMED